Arber C, Baerlocher G, Chalandon Y, Daskalakis M, Duchosal M, Fehr M, Gerull S, Güngör T, Nair G, Pabst T, Passweg JR, Piccolruaz B, Renner C, Ruefer A, Schneidawind D, Stüssi G, Zeerleder S, Halter JP. Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data. Swiss Med Wkly [Internet]. 2024 Oct. 3 [cited 2024 Dec. 11];154(10):3704. Available from: https://smw.ch/index.php/smw/article/view/3704